Status:
COMPLETED
ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs
Lead Sponsor:
Eisai Inc.
Collaborating Sponsors:
Eisai Farmacêutica S.A.
Conditions:
Epilepsy
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to acquire additional information about the appropriate level of dosing of Zonisamide when it is prescribed for patients with partial onset epileptic crisis who are alread...
Detailed Description
Patients from both sexes, 18 to 65 years of age, diagnosed with simple or complex partial onset epileptic crisis defined according to the International League Against Epilepsy (ILAE) criteria, with a ...
Eligibility Criteria
Inclusion
- Patients from both sexes, 18 to 65 years of age, diagnosed with simple or complex partial onset epileptic seizures defined according to the International League Against Epilepsy (ILAE) criteria, with a minimum of two crises within the 4 previous weeks, a stable treatment with two antiepileptic drugs for at least 12 weeks and capable and willing to give their informed consent, will be included.
Exclusion
- Those who do not fulfill the Inclusion requirements.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00659958
Start Date
April 1 2008
End Date
September 1 2009
Last Update
May 13 2013
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Complejo Hospitalario Universitario 'Juan Canalejo'
A Coruña, Galicia, Spain, 15006
2
C.H. A. Marcide Profesor Novoa Santos
Ferrol, Galicia, Spain, 15405
3
Centro Sanitario Complexo Hospitalario "XERAL-CALDE"
Lugo, Galicia, Spain, 27004
4
Hospital Comarcal de Monforte
Lugo, Galicia, Spain, 27400